From above all, our study implied that DAPA can protect against DCM and myocardial fibrosis through suppressing fibroblast activation and EndMT via AMPKα‐mediated inhibition of TGF‐β/Smad signalling. The gene discussed is TGFB1; the disease is familial dilated cardiomyopathy.